Search by Drug Name or NDC
NDC 73070-0203-15 Insulin Aspart Protamine and Insulin Aspart 100 [iU]/mL Details
Insulin Aspart Protamine and Insulin Aspart 100 [iU]/mL
Insulin Aspart Protamine and Insulin Aspart is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk Pharma, Inc.. The primary component is INSULIN ASPART.
Product Information
| NDC | 73070-0203 |
|---|---|
| Product ID | 73070-203_ec67820c-4008-4894-b933-34b28704221d |
| Associated GPIs | 2710407000D320 |
| GCN Sequence Number | 050134 |
| GCN Sequence Number Description | insulin aspart prot/insuln asp INSULN PEN 70-30/ML SUBCUT |
| HIC3 | C4G |
| HIC3 Description | INSULINS |
| GCN | 17075 |
| HICL Sequence Number | 023400 |
| HICL Sequence Number Description | INSULIN ASPART PROTAMINE HUMAN/INSULIN ASPART |
| Brand/Generic | Generic |
| Proprietary Name | Insulin Aspart Protamine and Insulin Aspart |
| Proprietary Name Suffix | Mix 70/30 |
| Non-Proprietary Name | insulin aspart |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SUSPENSION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | [iU]/mL |
| Substance Name | INSULIN ASPART |
| Labeler Name | Novo Nordisk Pharma, Inc. |
| Pharmaceutical Class | Insulin Analog [EPC], Insulin [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA021172 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 73070-0203-15 (73070020315)
| NDC Package Code | 73070-203-15 |
|---|---|
| Billing NDC | 73070020315 |
| Package | 5 SYRINGE, PLASTIC in 1 CARTON (73070-203-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-203-10) |
| Marketing Start Date | 2019-09-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 8.964 |
| Pricing Unit | ML |
| Effective Date | 2024-01-01 |
| NDC Description | INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 FLEXPEN |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis